Another study has linked commonly prescribed heartburn drugs to fatal health conditions. This isn’t the first time that research has shown that these drugs have serious side effects. Also linked to liver disease and kidney disease, it may be time to reconsider popping those antacids and looking for an alternative. The class of drugs that were looked at is called proton pump inhibitors (PPIs). These are commonly prescribed to treat gastrointestinal conditions that involve an excess of acid production. Nexium, Aciphex, Zegerid, Dexilant, Prevacid, Prilosec, and Protonix are only some of the brand names that PPIs have taken over the years. Continue reading “Heartburn Drugs Linked to Stomach Cancer & Heart Disease”
It seems new studies about proton pump inhibitors (PPIs) and their side effects come out every few months. Just over a year ago, a study linking them to kidney disease came out. And earlier in the same year, a link between PPIs and dementia was made. This week, a study was published where researchers from the University of California San Diego School of Medicine found a link between PPI use and chronic liver disease.
Proton pump inhibitors are a popular class of heartburn medications that includes Prilosec, Nexium and Prevacid. These medications, which are available over-the-counter (without a prescription), Continue reading “Heartburn Drugs Linked to Liver Disease”
Another reason to be wary of antacids. Research published online in the Journal of the American Society of Nephrology found that patients who regularly use proton pump inhibitors (PPIs) may be at increased risk of developing chronic kidney disease.
The new study findings are based on medical records from 173,321 Veterans Affairs patients who were prescribed a PPI and 20,270 other patients prescribed a histamine H2-receptor antagonist (H2-blocker). Over 5 years of follow-up, the results showed that 15% of people using PPIs were diagnosed with chronic kidney disease, versus 11% of those on H2-blockers. After the researchers weighed other factors, PPI users still had a 28% greater risk. Continue reading “Proton Pump Inhibitors Linked to Kidney Disease”